{"subnetworks": [{"diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CROHN'S DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "MULTIPLE MYELOMA", "RHEUMATOID ARTHRITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "IMMUNE SYSTEM DISEASE", "ULCERATIVE COLITIS", "CELIAC DISEASE", "HIV INFECTION", "ACNE", "PERIODONTITIS", "BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS", "MELANOMA", "RENAL CELL CARCINOMA"], "links": [{"source": "ENSG00000102962", "type": "stimulatory", "target": "ENSG00000126353"}, {"source": "ENSG00000102962", "type": "directed", "target": "ENSG00000162692", "reverse": "rev-directed"}, {"source": "ENSG00000102962", "type": "stimulatory", "target": "ENSG00000183813"}, {"source": "ENSG00000115232", "type": "directed", "target": "ENSG00000139626", "reverse": "rev-directed"}, {"source": "ENSG00000115232", "type": "directed", "target": "ENSG00000150093", "reverse": "rev-directed"}, {"source": "ENSG00000115232", "type": "stimulatory", "target": "ENSG00000162692", "reverse": "rev-stimulatory"}, {"source": "ENSG00000137673", "type": "stimulatory", "target": "ENSG00000196611"}, {"source": "ENSG00000139626", "type": "directed", "target": "ENSG00000162692"}, {"source": "ENSG00000150093", "type": "stimulatory", "target": "ENSG00000162692", "reverse": "rev-stimulatory"}, {"source": "ENSG00000150093", "type": "directed", "target": "ENSG00000164171", "reverse": "rev-directed"}, {"source": "ENSG00000164171", "target": "ENSG00000196611"}, {"source": "ENSG00000172270", "target": "ENSG00000196611"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP7", "MMP1"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}], "max_phase": 4, "name": "NATALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201607", "mechanisms": ["Integrin alpha-4/beta-1 inhibitor", "Integrin alpha-4/beta-7 inhibitor"], "genes": ["ITGA4", "ITGB7", "ITGB1"], "type": "Antibody", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CROHN'S DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "MULTIPLE MYELOMA", "RHEUMATOID ARTHRITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "IMMUNE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CELIAC DISEASE", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "VEDOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743087", "mechanisms": ["Integrin alpha-4/beta-7 inhibitor"], "genes": ["ITGA4", "ITGB7"], "type": "Antibody", "diseases": ["CROHN'S DISEASE", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CELIAC DISEASE", "HIV INFECTION"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP7", "MMP1"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 3}], "max_phase": 3, "name": "ETROLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743015", "mechanisms": ["Integrin beta-7 antagonist"], "genes": ["ITGB7"], "type": "Antibody", "diseases": ["ULCERATIVE COLITIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}], "max_phase": 3, "name": "VOLOCIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108061", "mechanisms": ["Integrin alpha-5/beta-1 antagonist"], "genes": ["ITGB1"], "type": "Antibody", "diseases": ["MELANOMA", "RENAL CELL CARCINOMA"]}, {"indications": [{"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}], "max_phase": 2, "name": "VATELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743086", "mechanisms": ["Integrin alpha-2 antagonist"], "genes": ["ITGA2"], "type": "Antibody", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ULCERATIVE COLITIS"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "FIRATEGRAST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104967", "mechanisms": ["Integrin alpha-4/beta-1 antagonist", "Integrin alpha-4/beta-7 antagonist"], "genes": ["ITGA4", "ITGB7", "ITGB1"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 1}], "max_phase": 2, "name": "INTETUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743032", "mechanisms": ["Integrin alpha-V/beta-1 antagonist"], "genes": ["ITGB1"], "type": "Antibody", "diseases": ["MELANOMA"]}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP7", "MMP1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DI17E6", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109621", "mechanisms": ["Integrin alpha-V/beta-1 inhibitor"], "genes": ["ITGB1"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 3, "name": "GAVILIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109193", "mechanisms": ["Basigin other"], "genes": ["BSG"], "type": "Antibody", "diseases": []}], "heat": 0.5839897696499999, "nodes": [{"assoc": 0.239727083256, "id": "ENSG00000102962", "label": "CCL22"}, {"assoc": 1.0, "id": "ENSG00000115232", "label": "ITGA4"}, {"assoc": 0.0552989344379, "id": "ENSG00000126353", "label": "CCR7"}, {"assoc": 1.0, "id": "ENSG00000137673", "label": "MMP7"}, {"assoc": 1.0, "id": "ENSG00000139626", "label": "ITGB7"}, {"assoc": 1.0, "id": "ENSG00000150093", "label": "ITGB1"}, {"assoc": 0.513015876378, "id": "ENSG00000162692", "label": "VCAM1"}, {"assoc": 0.25, "id": "ENSG00000164171", "label": "ITGA2"}, {"assoc": 0.0695134611111, "id": "ENSG00000172270", "label": "BSG"}, {"assoc": 0.296332110967, "id": "ENSG00000183813", "label": "CCR4"}, {"assoc": 1.0, "id": "ENSG00000196611", "label": "MMP1"}], "size": 11}, {"diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE", "PREGNANCY", "EPILEPSY", "SEIZURES", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "POST-OPERATIVE SIGN OR SYMPTOM", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "HIP FRACTURE", "RENAL INSUFFICIENCY", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY"], "links": [{"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000129682", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000161958", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000136531", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000007314", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000168356", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000183873", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000129159", "type": "manual", "target": "ENSG00000151150"}, {"source": "ENSG00000151150", "type": "manual", "target": "ENSG00000136531"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "HALLUX VALGUS", "stage": 3}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "BUPIVACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker", "Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN4A", "SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNC1"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 2}], "max_phase": 4, "name": "BUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200396", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["INGUINAL HERNIA", "PAIN"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "LEVOBUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["PREGNANCY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker", "Voltage-gated potassium channel blocker"], "genes": ["SCN4A", "KCNC1", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNC1"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNC1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type XI alpha subunit  blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN11A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}], "heat": 0.7692307692307693, "nodes": [{"assoc": 1.0, "id": "ENSG00000007314", "label": "SCN4A"}, {"assoc": 1.0, "id": "ENSG00000129159", "label": "KCNC1"}, {"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000144285", "label": "SCN1A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000168356", "label": "SCN11A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000129682", "label": "FGF13"}, {"assoc": 0, "id": "ENSG00000161958", "label": "FGF11"}, {"assoc": 0, "id": "ENSG00000151150", "label": "ANK3"}], "size": 13}, {"diseases": ["HEPATITIS B INFECTION", "FRIEDREICH ATAXIA", "RETINOPATHY", "NON-HODGKINS LYMPHOMA", "RHEUMATOID ARTHRITIS", "PSORIASIS", "CANCER", "HEPATITIS C INFECTION", "NEOPLASM", "OVARIAN CARCINOMA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "MELANOMA", "LEUKEMIA", "INFECTION", "MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ULCERATIVE COLITIS", "ASTHMA", "ALZHEIMERS DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "CHRONIC HEPATITIS B INFECTION", "HIV INFECTION", "PRIMARY MYELOFIBROSIS", "CHRONIC MYELOGENOUS LEUKEMIA", "HEPATITIS D", "INFLUENZA INFECTION", "HIV-1 INFECTION", "MULTIPLE MYELOMA", "RENAL INSUFFICIENCY", "HEPATOCELLULAR CARCINOMA", "ASTROCYTOMA", "CARCINOID TUMOR", "RENAL CELL CARCINOMA", "SEVERE ACUTE RESPIRATORY SYNDROME"], "links": [{"source": "ENSG00000027697", "target": "ENSG00000142166", "reverse": "rev-stimulatory"}, {"source": "ENSG00000027697", "type": "directed", "target": "ENSG00000159128", "reverse": "rev-directed"}, {"source": "ENSG00000105397", "type": "stimulatory", "target": "ENSG00000142166", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105397", "type": "directed", "target": "ENSG00000159110", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105397", "target": "ENSG00000171855", "reverse": "rev-stimulatory"}, {"source": "ENSG00000142166", "type": "directed", "target": "ENSG00000159110", "reverse": "rev-directed"}, {"source": "ENSG00000142166", "target": "ENSG00000171855", "reverse": "rev-stimulatory"}, {"source": "ENSG00000142166", "target": "ENSG00000188379", "reverse": "rev-stimulatory"}, {"source": "ENSG00000159110", "target": "ENSG00000171855", "reverse": "rev-stimulatory"}, {"source": "ENSG00000159110", "type": "directed", "target": "ENSG00000188379", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "CHRONIC HEPATITIS B INFECTION", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "ASTROCYTOMA", "stage": 2}, {"efo_term": "CARCINOID TUMOR", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 4, "name": "PEGINTERFERON ALFA-2B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201561", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CHRONIC HEPATITIS B INFECTION", "CHRONIC HEPATITIS C INFECTION", "HEPATITIS C INFECTION", "MELANOMA", "HIV-1 INFECTION", "CHRONIC MYELOGENOUS LEUKEMIA", "MULTIPLE MYELOMA", "RENAL INSUFFICIENCY", "HEPATOCELLULAR CARCINOMA", "ASTROCYTOMA", "CARCINOID TUMOR", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "CHRONIC HEPATITIS B INFECTION", "stage": 4}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 4}, {"efo_term": "HEPATITIS C INFECTION", "stage": 4}, {"efo_term": "HEPATITIS B INFECTION", "stage": 4}, {"efo_term": "HEPATITIS B INFECTION", "stage": 4}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "HEPATITIS D", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 2}], "max_phase": 4, "name": "PEGINTERFERON ALFA-2A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201560", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CHRONIC HEPATITIS B INFECTION", "CHRONIC HEPATITIS C INFECTION", "HEPATITIS C INFECTION", "HIV INFECTION", "MELANOMA", "HEPATITIS B INFECTION", "PRIMARY MYELOFIBROSIS", "CHRONIC MYELOGENOUS LEUKEMIA", "HEPATITIS D"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "INFECTION", "stage": 2}, {"efo_term": "HEPATITIS C INFECTION", "stage": 1}, {"efo_term": "OVARIAN CARCINOMA", "stage": 1}, {"efo_term": "LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "INTERFERON ALFA-2B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201558", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CANCER", "HEPATITIS C INFECTION", "NEOPLASM", "OVARIAN CARCINOMA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "MELANOMA", "LEUKEMIA", "INFECTION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 4, "name": "INTERFERON BETA-1A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201562", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ULCERATIVE COLITIS", "ASTHMA", "HEPATITIS C INFECTION", "ALZHEIMERS DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 1}], "max_phase": 4, "name": "INTERFERON ALFA-2A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108508", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CANCER", "MELANOMA", "RENAL CELL CARCINOMA", "PSORIASIS"]}, {"indications": [{"efo_term": "HEPATITIS B INFECTION", "stage": 2}, {"efo_term": "FRIEDREICH ATAXIA", "stage": 2}, {"efo_term": "RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "INTERFERON GAMA-1B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201564", "mechanisms": ["Interferon gamma receptor agonist"], "genes": ["IFNGR1", "IFNGR2"], "type": "Protein", "diseases": ["HEPATITIS B INFECTION", "FRIEDREICH ATAXIA", "RETINOPATHY"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "FRIEDREICH ATAXIA", "stage": 3}], "max_phase": 4, "name": "INTERFERON BETA-1B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201563", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "FRIEDREICH ATAXIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 4, "name": "PEGINTERFERON BETA-1A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108677", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 3, "name": "PEFICITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137308", "mechanisms": ["Janus Kinase (JAK) inhibitor"], "genes": ["TYK2"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "PSORIASIS"]}, {"indications": [{"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "CHRONIC HEPATITIS B INFECTION", "stage": 1}], "max_phase": 3, "name": "ALBINTERFERON ALFA-2B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107842", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CHRONIC HEPATITIS C INFECTION", "CHRONIC HEPATITIS B INFECTION"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "SEVERE ACUTE RESPIRATORY SYNDROME", "stage": 2}], "max_phase": 4, "name": "INTERFERON ALFA-N3", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109047", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["HIV INFECTION", "SEVERE ACUTE RESPIRATORY SYNDROME"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "Cerdulatinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545284", "mechanisms": ["Tyrosine-protein kinase TYK2  inhibitor"], "genes": ["TYK2"], "type": "Small molecule", "diseases": ["NON-HODGKINS LYMPHOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}], "max_phase": 4, "name": "TOFACITINIB CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103743", "mechanisms": ["Janus Kinase (JAK) inhibitor"], "genes": ["TYK2"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "INFLUENZA INFECTION", "stage": 1}], "max_phase": 4, "name": "INTERFERON ALFACON-1", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201557", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["INFLUENZA INFECTION"]}], "heat": 0.6959181853281714, "nodes": [{"assoc": 1.0, "id": "ENSG00000027697", "label": "IFNGR1"}, {"assoc": 0.651673380233, "id": "ENSG00000105397", "label": "TYK2"}, {"assoc": 1.0, "id": "ENSG00000142166", "label": "IFNAR1"}, {"assoc": 1.0, "id": "ENSG00000159110", "label": "IFNAR2"}, {"assoc": 1.0, "id": "ENSG00000159128", "label": "IFNGR2"}, {"assoc": 0.182045694842, "id": "ENSG00000171855", "label": "IFNB1"}, {"assoc": 0.0377082222222, "id": "ENSG00000188379", "label": "IFNA2"}], "size": 7}, {"diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE", "CANCER", "CHRONIC FATIGUE SYNDROME", "HODGKINS LYMPHOMA", "LYMPHOMA", "MEMBRANOUS GLOMERULONEPHRITIS", "NEOPLASM OF MATURE B-CELLS", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SYSTEMIC SCLERODERMA", "MALT LYMPHOMA", "METASTATIC MELANOMA", "MULTIPLE SCLEROSIS", "PROSTATE CARCINOMA", "WEGENER'S GRANULOMATOSIS", "DIFFUSE LARGE B-CELL LYMPHOMA", "HEMOPHILIA A", "KIDNEY DISEASE", "MYASTHENIA GRAVIS", "ACUTE LYMPHOBLASTIC LEUKEMIA", "LYMPHOPROLIFERATIVE DISORDER", "NEUROMYELITIS OPTICA", "SJOGREN SYNDROME", "MACROGLOBULINEMIA", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "NEPHROTIC SYNDROME", "NEUROPATHY", "ULCERATIVE COLITIS", "BEHCET'S SYNDROME", "LEUKEMIA", "TYPE I DIABETES MELLITUS", "SARCOIDOSIS", "MANTLE CELL LYMPHOMA", "NEOPLASM", "MICROSCOPIC POLYANGIITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ALVEOLAR PROTEINOSIS", "CHRONIC KIDNEY DISEASE", "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "PEMPHIGUS VULGARIS", "AGE-RELATED MACULAR DEGENERATION", "PROTEINURIA", "SCLERITIS", "BULLOUS PEMPHIGOID", "PERIPHERAL NEUROPATHY", "GRAVES OPHTHALMOPATHY", "MELANOMA", "IMMUNE SYSTEM DISEASE"], "links": [{"source": "ENSG00000101017", "target": "ENSG00000156738"}, {"source": "ENSG00000101017", "target": "ENSG00000162924", "reverse": "rev-directed"}, {"source": "ENSG00000156738", "target": "ENSG00000204287"}, {"source": "ENSG00000196126", "target": "ENSG00000204287", "reverse": "rev-directed"}, {"source": "ENSG00000198502", "target": "ENSG00000204287"}], "drugs": [{"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "WEGENER'S GRANULOMATOSIS", "stage": 4}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "MICROSCOPIC POLYANGIITIS", "stage": 4}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 3}, {"efo_term": "CHRONIC FATIGUE SYNDROME", "stage": 3}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 3}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "MALT LYMPHOMA", "stage": 3}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 3}, {"efo_term": "MYASTHENIA GRAVIS", "stage": 3}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "MANTLE CELL LYMPHOMA", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "stage": 3}, {"efo_term": "PEMPHIGUS VULGARIS", "stage": 3}, {"efo_term": "PROTEINURIA", "stage": 3}, {"efo_term": "BULLOUS PEMPHIGOID", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "MEMBRANOUS GLOMERULONEPHRITIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "HEMOPHILIA A", "stage": 2}, {"efo_term": "KIDNEY DISEASE", "stage": 2}, {"efo_term": "LYMPHOPROLIFERATIVE DISORDER", "stage": 2}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "MACROGLOBULINEMIA", "stage": 2}, {"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "BEHCET'S SYNDROME", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "ALVEOLAR PROTEINOSIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "METASTATIC MELANOMA", "stage": 1}, {"efo_term": "NEUROMYELITIS OPTICA", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 1}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 1}, {"efo_term": "SCLERITIS", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 0}], "max_phase": 4, "name": "RITUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201576", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["ACUTE GRAFT VS. HOST DISEASE", "CANCER", "CHRONIC FATIGUE SYNDROME", "HODGKINS LYMPHOMA", "LYMPHOMA", "MEMBRANOUS GLOMERULONEPHRITIS", "NEOPLASM OF MATURE B-CELLS", "NON-HODGKINS LYMPHOMA", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SYSTEMIC SCLERODERMA", "MALT LYMPHOMA", "METASTATIC MELANOMA", "MULTIPLE SCLEROSIS", "PROSTATE CARCINOMA", "WEGENER'S GRANULOMATOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "DIFFUSE LARGE B-CELL LYMPHOMA", "HEMOPHILIA A", "KIDNEY DISEASE", "MYASTHENIA GRAVIS", "ACUTE LYMPHOBLASTIC LEUKEMIA", "LYMPHOPROLIFERATIVE DISORDER", "NEUROMYELITIS OPTICA", "SJOGREN SYNDROME", "MACROGLOBULINEMIA", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "NEPHROTIC SYNDROME", "NEUROPATHY", "ULCERATIVE COLITIS", "BEHCET'S SYNDROME", "LEUKEMIA", "TYPE I DIABETES MELLITUS", "SARCOIDOSIS", "MANTLE CELL LYMPHOMA", "NEOPLASM", "MICROSCOPIC POLYANGIITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ALVEOLAR PROTEINOSIS", "CHRONIC KIDNEY DISEASE", "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "PEMPHIGUS VULGARIS", "AGE-RELATED MACULAR DEGENERATION", "PROTEINURIA", "SCLERITIS", "BULLOUS PEMPHIGOID", "PERIPHERAL NEUROPATHY", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "PEMPHIGUS VULGARIS", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "MANTLE CELL LYMPHOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 4, "name": "OFATUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201836", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA", "LEUKEMIA", "RHEUMATOID ARTHRITIS", "DIFFUSE LARGE B-CELL LYMPHOMA", "MULTIPLE SCLEROSIS", "HODGKINS LYMPHOMA", "ACUTE GRAFT VS. HOST DISEASE", "NON-HODGKINS LYMPHOMA", "CANCER", "NEOPLASM", "MELANOMA", "NEPHROTIC SYNDROME", "NEOPLASM OF MATURE B-CELLS", "PEMPHIGUS VULGARIS", "MANTLE CELL LYMPHOMA"]}, {"indications": [{"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 4, "name": "OCRELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108041", "mechanisms": ["B-lymphocyte antigen CD20 other"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "NON-HODGKINS LYMPHOMA", "RHEUMATOID ARTHRITIS", "IMMUNE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}], "max_phase": 4, "name": "OBINUTUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743048", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "NEOPLASM", "LYMPHOMA", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 2, "name": "DACETUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743005", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 inhibitor"], "genes": ["CD40"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "NEUROMYELITIS OPTICA", "stage": 1}], "max_phase": 3, "name": "UBLITUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108354", "mechanisms": ["B-lymphocyte antigen CD20 other"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["NEUROMYELITIS OPTICA", "MULTIPLE SCLEROSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}], "max_phase": 4, "name": "TOSITUMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201604", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "stage": 1}], "max_phase": 2, "name": "VELTUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743088", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "AUTOIMMUNE THROMBOCYTOPENIC PURPURA"]}, {"indications": [{"efo_term": "PSORIATIC ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PG-102", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109475", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 inhibitor"], "genes": ["CD40"], "type": "Antibody", "diseases": ["PSORIATIC ARTHRITIS"]}, {"indications": [], "max_phase": 2, "name": "TENELIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108144", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 partial agonist"], "genes": ["CD40"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 4, "name": "YTTRIUM Y 90 IBRITUMOMAB TIUXETAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108667", "mechanisms": ["B-lymphocyte antigen CD20 binding agent"], "genes": ["MS4A1"], "type": "Antibody", "diseases": []}], "heat": 0.5740859261955, "nodes": [{"assoc": 0.743932157773, "id": "ENSG00000101017", "label": "CD40"}, {"assoc": 1.0, "id": "ENSG00000156738", "label": "MS4A1"}, {"assoc": 0.4566323335, "id": "ENSG00000162924", "label": "REL"}, {"assoc": 0.200203679475, "id": "ENSG00000196126", "label": "HLA-DRB1"}, {"assoc": 0.159796135353, "id": "ENSG00000198502", "label": "HLA-DRB5"}, {"assoc": 0.883951251072, "id": "ENSG00000204287", "label": "HLA-DRA"}], "size": 6}, {"diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE", "CARDIAC ARRHYTHMIA"], "links": [{"source": "ENSG00000026559", "target": "ENSG00000158445"}, {"source": "ENSG00000158445", "target": "ENSG00000170745"}, {"source": "ENSG00000158445", "target": "ENSG00000171126"}, {"source": "ENSG00000158445", "target": "ENSG00000178342"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNB1", "KCNS3", "KCNG3", "KCNG2"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNB1", "KCNS3", "KCNG3", "KCNG2"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNB1", "KCNS3", "KCNG3", "KCNG2"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNB1", "KCNS3", "KCNG3", "KCNG2"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000026559", "label": "KCNG1"}, {"assoc": 1.0, "id": "ENSG00000158445", "label": "KCNB1"}, {"assoc": 1.0, "id": "ENSG00000170745", "label": "KCNS3"}, {"assoc": 1.0, "id": "ENSG00000171126", "label": "KCNG3"}, {"assoc": 1.0, "id": "ENSG00000178342", "label": "KCNG2"}], "size": 5}, {"diseases": ["EPILEPSY", "MIGRAINE DISORDER", "REFLEX SYMPATHETIC DYSTROPHY", "INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "ANXIETY", "RENAL INSUFFICIENCY", "MULTIPLE SCLEROSIS", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE", "CARDIAC ARRHYTHMIA"], "links": [{"source": "ENSG00000100346", "target": "ENSG00000184408", "reverse": "rev-directed"}, {"source": "ENSG00000102057", "target": "ENSG00000182132"}, {"source": "ENSG00000171385", "target": "ENSG00000182132", "reverse": "rev-directed"}, {"source": "ENSG00000182132", "target": "ENSG00000184408"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCND1", "KCND3", "KCND2"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 1}], "max_phase": 4, "name": "ETHOSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL696", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["EPILEPSY", "MIGRAINE DISORDER", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "TRIMETHADIONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL695", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL697", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL797", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PARAMETHADIONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCND1", "KCND3", "KCND2"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCND1", "KCND3", "KCND2"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [], "max_phase": 4, "name": "MIBEFRADIL DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1534525", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNA1I"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCND1", "KCND3", "KCND2"], "type": "Small molecule", "diseases": []}], "heat": 0.6543102865600001, "nodes": [{"assoc": 0.2, "id": "ENSG00000100346", "label": "CACNA1I"}, {"assoc": 1.0, "id": "ENSG00000102057", "label": "KCND1"}, {"assoc": 1.0, "id": "ENSG00000171385", "label": "KCND3"}, {"assoc": 0.0715514328, "id": "ENSG00000182132", "label": "KCNIP1"}, {"assoc": 1.0, "id": "ENSG00000184408", "label": "KCND2"}], "size": 5}, {"diseases": ["MULTIPLE MYELOMA", "MELANOMA", "OVARIAN CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "MALE BREAST CARCINOMA", "LYMPHOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC KIDNEY DISEASE", "ISCHEMIA REPERFUSION INJURY", "ACUTE MYELOID LEUKEMIA", "UVEITIS", "LEUKEMIA", "METASTATIC MELANOMA", "RENAL CARCINOMA", "TYPE I DIABETES MELLITUS", "CANCER", "HIV INFECTION", "RENAL CELL CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "CUTANEOUS MELANOMA", "NEUROBLASTOMA", "BREAST CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEPHROTIC SYNDROME", "LIVER DISEASE", "ALOPECIA AREATA", "PSORIASIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS"], "links": [{"source": "ENSG00000100385", "type": "stimulatory", "target": "ENSG00000134460", "reverse": "rev-directed"}, {"source": "ENSG00000100385", "type": "inhibitory", "target": "ENSG00000147168", "reverse": "rev-inhibitory"}, {"source": "ENSG00000104432", "type": "stimulatory", "target": "ENSG00000147168"}, {"source": "ENSG00000134460", "type": "inhibitory", "target": "ENSG00000147168", "reverse": "rev-directed"}, {"source": "ENSG00000138684", "type": "stimulatory", "target": "ENSG00000147168"}], "drugs": [{"indications": [{"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 1}, {"efo_term": "ALOPECIA AREATA", "stage": 1}], "max_phase": 4, "name": "HUMAN INTERLEUKIN-2", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201438", "mechanisms": ["Interleukin-2 receptor agonist"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Protein", "diseases": ["LEUKEMIA", "METASTATIC MELANOMA", "RENAL CARCINOMA", "TYPE I DIABETES MELLITUS", "ULCERATIVE COLITIS", "ACUTE MYELOID LEUKEMIA", "CANCER", "HIV INFECTION", "RENAL CELL CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "NEOPLASM", "MELANOMA", "CUTANEOUS MELANOMA", "NEUROBLASTOMA", "BREAST CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEPHROTIC SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "LIVER DISEASE", "ALOPECIA AREATA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 1}, {"efo_term": "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "DENILEUKIN DIFTITOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201550", "mechanisms": ["Interleukin-2 receptor binding agent"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Protein", "diseases": ["MULTIPLE MYELOMA", "MELANOMA", "OVARIAN CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "MALE BREAST CARCINOMA", "LYMPHOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ISCHEMIA REPERFUSION INJURY", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "BASILIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201439", "mechanisms": ["Interleukin-2 receptor inhibitor"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Antibody", "diseases": ["NEOPLASM", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "ISCHEMIA REPERFUSION INJURY", "ACUTE MYELOID LEUKEMIA", "UVEITIS"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 1}], "max_phase": 4, "name": "DACLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201605", "mechanisms": ["Interleukin-2 receptor inhibitor"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Antibody", "diseases": ["PSORIASIS", "IMMUNE SYSTEM DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 2, "name": "LMB-2", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109367", "mechanisms": ["Interleukin-2 receptor alpha chain binding agent"], "genes": ["IL2RA"], "type": "Antibody", "diseases": ["LEUKEMIA", "LYMPHOMA"]}, {"indications": [], "max_phase": 2, "name": "INOLIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108370", "mechanisms": ["Interleukin-2 receptor alpha chain antagonist"], "genes": ["IL2RA"], "type": "Antibody", "diseases": []}], "heat": 0.62776212453944, "nodes": [{"assoc": 1.0, "id": "ENSG00000100385", "label": "IL2RB"}, {"assoc": 0.0823209094111, "id": "ENSG00000104432", "label": "IL7"}, {"assoc": 1.0, "id": "ENSG00000134460", "label": "IL2RA"}, {"assoc": 0.0564897132861, "id": "ENSG00000138684", "label": "IL21"}, {"assoc": 1.0, "id": "ENSG00000147168", "label": "IL2RG"}], "size": 5}, {"diseases": ["CARDIOVASCULAR DISEASE", "NEPHROTIC SYNDROME", "CONGESTIVE HEART FAILURE", "CIRRHOSIS OF LIVER", "HYPERTENSION", "CARDIAC ARRHYTHMIA", "CYSTIC FIBROSIS", "IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "SMOKING CESSATION", "PAIN", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE", "OBESITY", "TYPE II DIABETES MELLITUS", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "OBSESSIVE-COMPULSIVE DISORDER", "LIVER DISEASE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "MYOCARDIAL ISCHEMIA", "DIABETIC FOOT", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "MYOCARDIAL INFARCTION", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "HEART FAILURE", "OCULAR HYPERTENSION", "FEVER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "SEPSIS", "INJURY", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC", "ARTHRALGIA", "MYALGIA", "AMYOTROPHIC LATERAL SCLEROSIS", "COUGH", "FROZEN SHOULDER", "TENDINOPATHY", "CYSTINOSIS", "PROSTATE CARCINOMA", "DIABETIC NEUROPATHY", "DISORDER OF LIPID METABOLISM", "PRURITUS", "RHINITIS", "ATOPIC ECZEMA", "NEUROGENIC BLADDER", "ROSACEA", "SEBORRHEIC DERMATITIS"], "links": [{"source": "ENSG00000111319", "target": "ENSG00000196689"}, {"source": "ENSG00000118432", "target": "ENSG00000128271"}, {"source": "ENSG00000118432", "type": "inhibitory", "target": "ENSG00000196689"}, {"source": "ENSG00000128271", "target": "ENSG00000163485"}], "drugs": [{"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "COMMON COLD", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "ABDOMINAL PAIN", "stage": 3}, {"efo_term": "BACTERIAL MENINGITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 2}, {"efo_term": "CLEFT PALATE", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 2}, {"efo_term": "GLAUCOMA", "stage": 0}], "max_phase": 4, "name": "ACETAMINOPHEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112", "mechanisms": ["Vanilloid receptor opener"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["FEVER", "MIGRAINE DISORDER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "PATENT DUCTUS ARTERIOSUS", "HYPERTENSION", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "SEPSIS", "INJURY", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC"]}, {"indications": [{"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 2}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 0}, {"efo_term": "MIGRAINE DISORDER", "stage": 0}, {"efo_term": "CYSTINOSIS", "stage": 0}, {"efo_term": "INJURY", "stage": 0}], "max_phase": 4, "name": "CAPSAICIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199", "mechanisms": ["Vanilloid receptor opener"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["PAIN", "ARTHRALGIA", "MYALGIA", "AMYOTROPHIC LATERAL SCLEROSIS", "OSTEOARTHRITIS", "COUGH", "PULMONARY HYPERTENSION", "ARTHRITIS", "FROZEN SHOULDER", "TENDINOPATHY", "PARKINSON'S DISEASE", "MIGRAINE DISORDER", "CYSTINOSIS", "PROSTATE CARCINOMA", "DIABETIC NEUROPATHY", "DISORDER OF LIPID METABOLISM", "PRURITUS", "INJURY", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}], "max_phase": 3, "name": "CANNABIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190461", "mechanisms": ["Cannabinoid CB1 receptor Negative allosteric modulator"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PAIN", "MARIJUANA DEPENDENCE", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "DRUG DEPENDENCE", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "DRONABINOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "SPASTICITY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 1}], "max_phase": 4, "name": "NABILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218896", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["NAUSEA", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "MARIJUANA DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 4}], "max_phase": 4, "name": "TRIAMTERENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL585", "mechanisms": ["Amiloride-sensitive sodium channel, ENaC blocker"], "genes": ["SCNN1A"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "NEPHROTIC SYNDROME", "CONGESTIVE HEART FAILURE", "CIRRHOSIS OF LIVER"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "SEBORRHEIC DERMATITIS", "stage": 2}], "max_phase": 3, "name": "PAC-14028", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707398", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ROSACEA", "PRURITUS", "SEBORRHEIC DERMATITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "AMILORIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1398126", "mechanisms": ["Amiloride-sensitive sodium channel, ENaC blocker"], "genes": ["SCNN1A"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CONGESTIVE HEART FAILURE", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "RHINITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 1}], "max_phase": 2, "name": "SB-705498", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207433", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["COUGH", "RHINITIS", "ATOPIC ECZEMA"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "TARANABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220360", "mechanisms": ["Cannabinoid CB1 receptor inverse agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "IBIPINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL412262", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}], "max_phase": 3, "name": "ROLOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103819", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE", "CONGESTIVE HEART FAILURE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "ANGINA PECTORIS", "stage": 2}], "max_phase": 2, "name": "Capadenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3235279", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "SAF312", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544953", "mechanisms": ["Vanilloid receptor inhibitor"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AZD1386", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545039", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN"]}, {"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "XEN-D0501", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707293", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["COUGH", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 2, "name": "P-1037", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545352", "mechanisms": ["Amiloride-sensitive sodium channel, ENaC blocker"], "genes": ["SCNN1A"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 2, "name": "SURINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189676", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SMOKING CESSATION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "Drinabant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545166", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "PBF-680", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545162", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 2}], "max_phase": 2, "name": "BAY1067197", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545405", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE"]}, {"indications": [{"efo_term": "OCULAR HYPERTENSION", "stage": 3}], "max_phase": 3, "name": "Trabodenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545407", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 1}], "max_phase": 1, "name": "MAVATREP", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364618", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS"]}, {"indications": [], "max_phase": 3, "name": "OTENABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562668", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NONABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106841", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD2207", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545289", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SAD448", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545387", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist", "Adenosine A1 receptor agonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FK453", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440115", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "TONAPOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414157", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TECADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL392149", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Derenofylline", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592435", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SELODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107371", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NAXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107805", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS-9667", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545011", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GW493838", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545223", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RPR749", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545331", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AMG-517", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL229430", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ABT-102", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398338", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GRC-6211", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545107", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PHE377", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545148", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NGD-8243", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545227", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "JTS-653", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545228", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DWP05195", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545229", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SYL-1001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707356", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "MR-1817", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707397", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}], "heat": 0.72, "nodes": [{"assoc": 0.2, "id": "ENSG00000111319", "label": "SCNN1A"}, {"assoc": 1.0, "id": "ENSG00000118432", "label": "CNR1"}, {"assoc": 0.7, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 0.7, "id": "ENSG00000163485", "label": "ADORA1"}, {"assoc": 1.0, "id": "ENSG00000196689", "label": "TRPV1"}], "size": 5}, {"diseases": ["EPILEPSY", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "TINNITUS", "PAIN", "NEUROPATHIC PAIN", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000176884", "target": "ENSG00000273079", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}, {"assoc": 1.0, "id": "ENSG00000273079", "label": "GRIN2B"}], "size": 5}, {"diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE", "CARDIAC ARRHYTHMIA", "EPILEPSY", "SEIZURES", "AMYOTROPHIC LATERAL SCLEROSIS", "UNIPOLAR DEPRESSION", "CANCER", "MELANOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "PSORIASIS", "ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "LIVER DISEASE", "NEOPLASM", "RECTUM CANCER"], "links": [{"source": "ENSG00000075043", "target": "ENSG00000184156"}, {"source": "ENSG00000117013", "target": "ENSG00000184156"}, {"source": "ENSG00000053918", "type": "manual", "target": "ENSG00000180509"}, {"source": "ENSG00000180509", "type": "manual", "target": "ENSG00000154229"}, {"source": "ENSG00000154229", "type": "manual", "target": "ENSG00000075043"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNQ1", "KCNQ2", "KCNQ4", "KCNQ3"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "EZOGABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355", "mechanisms": ["KCNQ (Kv7) potassium channel blocker"], "genes": ["KCNQ1", "KCNQ2", "KCNQ4", "KCNQ3"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "AMYOTROPHIC LATERAL SCLEROSIS", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 3, "name": "MIDOSTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "LIVER DISEASE", "NEOPLASM", "RECTUM CANCER"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "POSTERIOR UVEITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "SOTRASTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565612", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "PSORIASIS"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNQ1", "KCNQ2", "KCNQ4", "KCNQ3"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNQ1", "KCNQ2", "KCNQ4", "KCNQ3"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "GSK-690693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494089", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}], "max_phase": 2, "name": "(7S)-HYDROXYL-STAUROSPORINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL574737", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["MELANOMA"]}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNQ1", "KCNQ2", "KCNQ4", "KCNQ3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "FLINDOKALNER", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266510", "mechanisms": ["Voltage-gated potassium channel subunit Kv7.2 activator", "Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator", "Voltage-gated potassium channel subunit Kv7.4 activator", "Voltage-gated potassium channel KCNQ3/KCNQ4 activator"], "genes": ["KCNQ2", "KCNQ4", "KCNQ3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEP-2563", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545332", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": []}], "heat": 0.6666666666666666, "nodes": [{"assoc": 1.0, "id": "ENSG00000053918", "label": "KCNQ1"}, {"assoc": 1.0, "id": "ENSG00000075043", "label": "KCNQ2"}, {"assoc": 1.0, "id": "ENSG00000117013", "label": "KCNQ4"}, {"assoc": 1.0, "id": "ENSG00000184156", "label": "KCNQ3"}, {"assoc": 0, "id": "ENSG00000180509", "label": "KCNE1"}, {"assoc": 0, "id": "ENSG00000154229", "label": "PRKCA"}], "size": 6}, {"diseases": ["NEUTROPENIA", "LEUKEMIA", "NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "BREAST CARCINOMA", "LYMPHOMA", "BREAST NEOPLASM", "LYMPHOID NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "CIRRHOSIS OF LIVER", "NEOPLASM", "CHAGAS CARDIOMYOPATHY", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "ACUTE MYELOID LEUKEMIA", "INFERTILITY", "AMYOTROPHIC LATERAL SCLEROSIS", "MYELODYSPLASTIC SYNDROME", "SARCOMA", "PARKINSON'S DISEASE", "RESPIRATORY FAILURE", "NEOPLASM OF MATURE B-CELLS", "PROSTATE CARCINOMA", "HEPATITIS, ALCOHOLIC", "RETINOBLASTOMA", "PERIPHERAL ARTERIAL DISEASE", "EWING SARCOMA", "PSORIASIS", "RHEUMATOID ARTHRITIS", "MULTIPLE SCLEROSIS"], "links": [{"source": "ENSG00000108342", "type": "stimulatory", "target": "ENSG00000119535"}, {"source": "ENSG00000119535", "target": "ENSG00000164400", "reverse": "rev-stimulatory"}, {"source": "ENSG00000119535", "target": "ENSG00000170890"}], "drugs": [{"indications": [{"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "CHAGAS CARDIOMYOPATHY", "stage": 3}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 3}, {"efo_term": "NEUTROPENIA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "RETINOBLASTOMA", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 2}, {"efo_term": "INFERTILITY", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 1}], "max_phase": 4, "name": "FILGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201567", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Protein", "diseases": ["CIRRHOSIS OF LIVER", "LEUKEMIA", "NEOPLASM", "CHAGAS CARDIOMYOPATHY", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "ACUTE MYELOID LEUKEMIA", "INFERTILITY", "MULTIPLE MYELOMA", "NON-SMALL CELL LUNG CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "NEUTROPENIA", "MYELODYSPLASTIC SYNDROME", "LYMPHOMA", "SARCOMA", "PARKINSON'S DISEASE", "RESPIRATORY FAILURE", "BREAST CARCINOMA", "NEOPLASM OF MATURE B-CELLS", "NON-HODGKINS LYMPHOMA", "LYMPHOID NEOPLASM", "PROSTATE CARCINOMA", "HEPATITIS, ALCOHOLIC", "RETINOBLASTOMA", "PERIPHERAL ARTERIAL DISEASE"]}, {"indications": [{"efo_term": "NEUTROPENIA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}], "max_phase": 4, "name": "PEGFILGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201568", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Protein", "diseases": ["NEUTROPENIA", "LEUKEMIA", "NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "BREAST CARCINOMA", "LYMPHOMA", "BREAST NEOPLASM", "LYMPHOID NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 3}, {"efo_term": "EWING SARCOMA", "stage": 1}], "max_phase": 4, "name": "LIPEGFILGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105765", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Small molecule", "diseases": ["LYMPHOMA", "EWING SARCOMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "NAMILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743044", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 2, "name": "MOR-103", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109433", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "BALUGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108572", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Protein", "diseases": ["NEOPLASM"]}, {"indications": [], "max_phase": 2, "name": "KB-003", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109431", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": []}], "heat": 0.24449501661700002, "nodes": [{"assoc": 0.0517077887984, "id": "ENSG00000108342", "label": "CSF3"}, {"assoc": 0.736111111111, "id": "ENSG00000119535", "label": "CSF3R"}, {"assoc": 0.132825935518, "id": "ENSG00000164400", "label": "CSF2"}, {"assoc": 0.0573352310406, "id": "ENSG00000170890", "label": "PLA2G1B"}], "size": 4}, {"diseases": [], "links": [{"source": "ENSG00000013725", "target": "ENSG00000110448"}, {"source": "ENSG00000013725", "target": "ENSG00000170017", "reverse": "rev-directed"}], "drugs": [{"indications": [], "max_phase": 2, "name": "ONCOLYSIN CD6", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109485", "mechanisms": ["T-cell differentiation antigen CD6 binding agent"], "genes": ["CD6"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZOLIMOMAB ARITOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108785", "mechanisms": ["T-cell surface glycoprotein CD5 binding agent"], "genes": ["CD5"], "type": "Antibody", "diseases": []}], "heat": 0.3709279135256, "nodes": [{"assoc": 0.639082520805, "id": "ENSG00000013725", "label": "CD6"}, {"assoc": 0.426379566994, "id": "ENSG00000110448", "label": "CD5"}, {"assoc": 0.0473216527778, "id": "ENSG00000170017", "label": "ALCAM"}], "size": 3}, {"diseases": ["LEUKEMIA", "MELANOMA", "SICKLE CELL ANEMIA", "CENTRAL NERVOUS SYSTEM CANCER", "ESSENTIAL THROMBOCYTHEMIA", "MULTIPLE SCLEROSIS", "POLYCYTHEMIA VERA", "BETA-THALASSEMIA INTERMEDIA", "MYELODYSPLASTIC SYNDROME", "MENINGIOMA", "FIBROMATOSIS", "NEOPLASM", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "BLADDER CARCINOMA", "BREAST CARCINOMA", "MESOTHELIOMA", "OVARIAN CARCINOMA", "SARCOMA", "ACUTE MYELOID LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "NEOPLASM OF MATURE B-CELLS", "MULTIPLE MYELOMA", "HISTIOCYTOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "CHRONIC MYELOMONOCYTIC LEUKEMIA", "LYMPHOMA", "APLASTIC ANEMIA", "LYMPHOID LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "CUTANEOUS MELANOMA", "CYSTIC FIBROSIS", "CANCER"], "links": [{"source": "ENSG00000048392", "type": "directed", "target": "ENSG00000167325"}, {"source": "ENSG00000048392", "type": "directed", "target": "ENSG00000171848", "reverse": "rev-directed"}, {"source": "ENSG00000167325", "target": "ENSG00000171848", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "ESSENTIAL THROMBOCYTHEMIA", "stage": 3}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 3}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "BETA-THALASSEMIA INTERMEDIA", "stage": 2}, {"efo_term": "MENINGIOMA", "stage": 2}, {"efo_term": "FIBROMATOSIS", "stage": 2}], "max_phase": 4, "name": "HYDROXYUREA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MELANOMA", "SICKLE CELL ANEMIA", "CENTRAL NERVOUS SYSTEM CANCER", "ESSENTIAL THROMBOCYTHEMIA", "MULTIPLE SCLEROSIS", "POLYCYTHEMIA VERA", "BETA-THALASSEMIA INTERMEDIA", "MYELODYSPLASTIC SYNDROME", "MENINGIOMA", "FIBROMATOSIS", "NEOPLASM", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "HISTIOCYTOSIS", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC MYELOMONOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "CLOFARABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MYELODYSPLASTIC SYNDROME", "ACUTE MYELOID LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "NEOPLASM", "NEOPLASM OF MATURE B-CELLS", "MULTIPLE MYELOMA", "HISTIOCYTOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "CHRONIC MYELOMONOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "OVARIAN CARCINOMA", "stage": 4}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GEMCITABINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1637", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["LUNG CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "BLADDER CARCINOMA", "BREAST CARCINOMA", "LEUKEMIA", "MESOTHELIOMA", "OVARIAN CARCINOMA", "SARCOMA"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "LYMPHOID LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "SARCOMA", "stage": 1}, {"efo_term": "APLASTIC ANEMIA", "stage": 1}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 1}], "max_phase": 4, "name": "FLUDARABINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096882", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA", "ACUTE MYELOID LEUKEMIA", "NEOPLASM", "SARCOMA", "SICKLE CELL ANEMIA", "APLASTIC ANEMIA", "LYMPHOID LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 4, "name": "GALLIUM NITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200983", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "TEZACITABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105467", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["CANCER"]}], "heat": 0.250331953825, "nodes": [{"assoc": 0.25, "id": "ENSG00000048392", "label": "RRM2B"}, {"assoc": 0.25, "id": "ENSG00000167325", "label": "RRM1"}, {"assoc": 0.250995861475, "id": "ENSG00000171848", "label": "RRM2"}], "size": 3}, {"diseases": ["GASTROESOPHAGEAL REFLUX DISEASE", "MULTIPLE SCLEROSIS", "CIRRHOSIS OF LIVER", "COCAINE DEPENDENCE", "MARIJUANA DEPENDENCE", "NICOTINE DEPENDENCE", "SPASTICITY", "ALCOHOL WITHDRAWAL", "ALCOHOL DEPENDENCE", "AUTISM", "FRAGILE X SYNDROME", "AUTISM SPECTRUM DISORDER", "EATING DISORDER", "FIBROMYALGIA", "ALTERNATING HEMIPLEGIA OF CHILDHOOD", "NARCOLEPSY WITH CATAPLEXY", "PARKINSON'S DISEASE", "ESSENTIAL TREMOR", "PAIN", "SCHIZOPHRENIA"], "links": [{"source": "ENSG00000136928", "target": "ENSG00000204681"}, {"source": "ENSG00000054523", "type": "manual", "target": "ENSG00000152969"}, {"source": "ENSG00000152969", "type": "manual", "target": "ENSG00000204681"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "SPASTICITY", "stage": 4}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "AUTISM", "stage": 1}], "max_phase": 4, "name": "BACLOFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701", "mechanisms": ["GABA-B receptor agonist"], "genes": ["GABBR2", "GABBR1"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "CIRRHOSIS OF LIVER", "COCAINE DEPENDENCE", "MARIJUANA DEPENDENCE", "NICOTINE DEPENDENCE", "SPASTICITY", "ALCOHOL WITHDRAWAL", "ALCOHOL DEPENDENCE", "AUTISM"]}, {"indications": [{"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ALTERNATING HEMIPLEGIA OF CHILDHOOD", "stage": 1}], "max_phase": 4, "name": "SODIUM OXYBATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200682", "mechanisms": ["GABA-B receptor agonist"], "genes": ["GABBR2", "GABBR1"], "type": "Small molecule", "diseases": ["EATING DISORDER", "FIBROMYALGIA", "ALTERNATING HEMIPLEGIA OF CHILDHOOD", "NARCOLEPSY WITH CATAPLEXY", "PARKINSON'S DISEASE", "ESSENTIAL TREMOR", "PAIN", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "FRAGILE X SYNDROME", "stage": 3}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 0}], "max_phase": 3, "name": "ARBACLOFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301742", "mechanisms": ["GABA-B receptor agonist"], "genes": ["GABBR2", "GABBR1"], "type": "Small molecule", "diseases": ["AUTISM", "FRAGILE X SYNDROME", "AUTISM SPECTRUM DISORDER"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 2}], "max_phase": 3, "name": "ARBACLOFEN PLACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107312", "mechanisms": ["GABA-B receptor agonist"], "genes": ["GABBR2", "GABBR1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "MULTIPLE SCLEROSIS", "GASTROESOPHAGEAL REFLUX DISEASE"]}, {"indications": [{"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 2}], "max_phase": 2, "name": "Lesogaberan", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448343", "mechanisms": ["GABA-B receptor 2 agonist", "GABA-B receptor 1 agonist"], "genes": ["GABBR2", "GABBR1"], "type": "Small molecule", "diseases": ["GASTROESOPHAGEAL REFLUX DISEASE"]}], "heat": 0.60624618484, "nodes": [{"assoc": 0.42498473936, "id": "ENSG00000054523", "label": "KIF1B"}, {"assoc": 1.0, "id": "ENSG00000136928", "label": "GABBR2"}, {"assoc": 1.0, "id": "ENSG00000204681", "label": "GABBR1"}, {"assoc": 0, "id": "ENSG00000152969", "label": "JAKMIP1"}], "size": 4}, {"diseases": ["RHEUMATOID ARTHRITIS", "SJOGREN SYNDROME"], "links": [{"source": "ENSG00000067182", "type": "directed", "target": "ENSG00000226979", "reverse": "rev-stimulatory"}, {"source": "ENSG00000226979", "target": "ENSG00000227507"}], "drugs": [{"indications": [{"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "BAMINERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742988", "mechanisms": ["Heterotrimeric lymphotoxin LTa1b2 inhibitor"], "genes": ["LTA", "LTB"], "type": "Protein", "diseases": ["SJOGREN SYNDROME", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PATECLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743056", "mechanisms": ["TNF-beta inhibitor"], "genes": ["LTA"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}], "heat": 0.4062527794883333, "nodes": [{"assoc": 1.0, "id": "ENSG00000067182", "label": "TNFRSF1A"}, {"assoc": 0.113942088465, "id": "ENSG00000226979", "label": "LTA"}, {"assoc": 0.10481625, "id": "ENSG00000227507", "label": "LTB"}], "size": 3}, {"diseases": ["ANKYLOSING SPONDYLITIS", "ATOPIC ECZEMA", "PSORIASIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "UVEITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ULCERATIVE COLITIS", "HIDRADENITIS SUPPURATIVA", "MULTIPLE SCLEROSIS"], "links": [{"source": "ENSG00000110944", "type": "directed", "target": "ENSG00000113302", "reverse": "rev-directed"}, {"source": "ENSG00000113302", "target": "ENSG00000168811", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "USTEKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201835", "mechanisms": ["Interleukin-23 inhibitor", "Interleukin-12 inhibitor"], "genes": ["IL23A", "IL12B", "IL12A"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "ATOPIC ECZEMA", "PSORIASIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "UVEITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ULCERATIVE COLITIS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 3, "name": "BRIAKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742995", "mechanisms": ["Interleukin-23 inhibitor", "Interleukin-12 inhibitor", "Interleukin-12 subunit beta inhibitor"], "genes": ["IL23A", "IL12B", "IL12A"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "PSORIASIS", "MULTIPLE SCLEROSIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "TILDRAKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108681", "mechanisms": ["Interleukin-23 subunit alpha inhibitor"], "genes": ["IL23A"], "type": "Antibody", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "GUSELKUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364648", "mechanisms": ["Interleukin-23 subunit alpha inhibitor"], "genes": ["IL23A"], "type": "Antibody", "diseases": ["PSORIASIS"]}], "heat": 0.42334809575433335, "nodes": [{"assoc": 0.264302166667, "id": "ENSG00000110944", "label": "IL23A"}, {"assoc": 0.349285127453, "id": "ENSG00000113302", "label": "IL12B"}, {"assoc": 0.656456993143, "id": "ENSG00000168811", "label": "IL12A"}], "size": 3}, {"diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "AMYOTROPHIC LATERAL SCLEROSIS", "OPTIC NEURITIS"], "links": [{"source": "ENSG00000115310", "type": "stimulatory", "target": "ENSG00000169783"}, {"source": "ENSG00000126861", "type": "stimulatory", "target": "ENSG00000169783"}], "drugs": [{"indications": [{"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 2, "name": "OZANEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108679", "mechanisms": ["Reticulon-4 inhibitor"], "genes": ["RTN4"], "type": "Antibody", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 2, "name": "OPICINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544922", "mechanisms": ["Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 inhibitor"], "genes": ["LINGO1"], "type": "Antibody", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "OPTIC NEURITIS", "MULTIPLE SCLEROSIS"]}], "heat": 0.14496159851846666, "nodes": [{"assoc": 0.1260945, "id": "ENSG00000115310", "label": "RTN4"}, {"assoc": 0.0352911844444, "id": "ENSG00000126861", "label": "OMG"}, {"assoc": 0.273499111111, "id": "ENSG00000169783", "label": "LINGO1"}], "size": 3}, {"diseases": ["NEUROMYELITIS OPTICA", "CHRONIC CHILDHOOD ARTHRITIS", "RHEUMATOID ARTHRITIS", "SCHIZOPHRENIA", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "IMMUNE SYSTEM DISEASE", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION", "UVEITIS", "TYPE I DIABETES MELLITUS", "GRAVES OPHTHALMOPATHY"], "links": [{"source": "ENSG00000128342", "type": "stimulatory", "target": "ENSG00000134352"}, {"source": "ENSG00000134352", "target": "ENSG00000160712", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 3}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "FIBROUS DYSPLASIA OF BONE", "stage": 2}, {"efo_term": "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "TOCILIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237022", "mechanisms": ["Interleukin-6 receptor alpha subunit inhibitor"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["CHRONIC CHILDHOOD ARTHRITIS", "RHEUMATOID ARTHRITIS", "SCHIZOPHRENIA", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "IMMUNE SYSTEM DISEASE", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION", "UVEITIS", "TYPE I DIABETES MELLITUS", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}], "max_phase": 3, "name": "SARILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108730", "mechanisms": ["Interleukin-6 receptor alpha subunit antagonist"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC CHILDHOOD ARTHRITIS"]}, {"indications": [{"efo_term": "NEUROMYELITIS OPTICA", "stage": 3}], "max_phase": 0, "name": "SA237", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833307", "mechanisms": ["IL6Ralpha/GP130 antagonist"], "genes": ["IL6ST", "IL6R"], "type": "Antibody", "diseases": ["NEUROMYELITIS OPTICA"]}], "heat": 0.6157762409629667, "nodes": [{"assoc": 0.0552705006669, "id": "ENSG00000128342", "label": "LIF"}, {"assoc": 0.879577, "id": "ENSG00000134352", "label": "IL6ST"}, {"assoc": 0.912481222222, "id": "ENSG00000160712", "label": "IL6R"}], "size": 3}, {"diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE", "CARDIAC ARRHYTHMIA"], "links": [{"source": "ENSG00000130037", "target": "ENSG00000177301"}, {"source": "ENSG00000177301", "target": "ENSG00000182255"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA5", "KCNA2", "KCNA4"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA5", "KCNA2", "KCNA4"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA5", "KCNA2", "KCNA4"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA5", "KCNA2", "KCNA4"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000130037", "label": "KCNA5"}, {"assoc": 1.0, "id": "ENSG00000177301", "label": "KCNA2"}, {"assoc": 1.0, "id": "ENSG00000182255", "label": "KCNA4"}], "size": 3}, {"diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME", "FEVER", "PAIN", "NEUROPATHIC PAIN", "DIABETIC NEUROPATHY", "INSOMNIA", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "PROSTATE CARCINOMA", "CARPAL TUNNEL SYNDROME", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY"], "links": [{"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000165995", "reverse": "rev-directed"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000167535"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1B", "CACNB2", "CACNB3"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1B", "CACNB2", "CACNB3"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1B", "CACNB2", "CACNB3"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1B", "CACNB2", "CACNB3"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1B", "CACNB2", "CACNB3"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNA1B", "CACNB2", "CACNB3"], "type": "Small molecule", "diseases": []}], "heat": 0.46667025277499996, "nodes": [{"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 0.2, "id": "ENSG00000165995", "label": "CACNB2"}, {"assoc": 0.200010758325, "id": "ENSG00000167535", "label": "CACNB3"}], "size": 3}], "auto_delta": "0.00429301"}